<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR58">
 <label>58.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Marso</surname>
    <given-names>SP</given-names>
   </name>
   <name>
    <surname>Daniels</surname>
    <given-names>GH</given-names>
   </name>
   <name>
    <surname>Brown-Frandsen</surname>
    <given-names>K</given-names>
   </name>
   <name>
    <surname>Kristensen</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Mann</surname>
    <given-names>JF</given-names>
   </name>
   <name>
    <surname>Nauck</surname>
    <given-names>MA</given-names>
   </name>
   <name>
    <surname>Nissen</surname>
    <given-names>SE</given-names>
   </name>
   <name>
    <surname>Pocock</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Poulter</surname>
    <given-names>NR</given-names>
   </name>
   <name>
    <surname>Ravn</surname>
    <given-names>LS</given-names>
   </name>
   <name>
    <surname>Steinberg</surname>
    <given-names>WM</given-names>
   </name>
   <name>
    <surname>Stockner</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Zinman</surname>
    <given-names>B</given-names>
   </name>
   <name>
    <surname>Bergenstal</surname>
    <given-names>RM</given-names>
   </name>
   <name>
    <surname>Buse</surname>
    <given-names>JB</given-names>
   </name>
  </person-group>
  <article-title>LEADER steering committee, LEADER trial investigators. liraglutide and cardiovascular outcomes in type 2 diabetes</article-title>
  <source>N Engl J Med</source>
  <year>2016</year>
  <volume>375</volume>
  <fpage>311</fpage>
  <lpage>322</lpage>
  <pub-id pub-id-type="doi">10.1056/NEJMoa1603827</pub-id>
  <?supplied-pmid 27295427?>
  <pub-id pub-id-type="pmid">27295427</pub-id>
 </element-citation>
</ref>
